Stephan Schroll

Summary

Affiliation: University of Regensburg
Country: Germany

Publications

  1. doi request reprint Effects of simvastatin on pulmonary fibrosis, pulmonary hypertension and exercise capacity in bleomycin-treated rats
    S Schroll
    Department of Internal Medicine II, Pneumology, University of Regensburg, Regensburg, Germany
    Acta Physiol (Oxf) 208:191-201. 2013
  2. doi request reprint Improvement of exercise capacity in monocrotaline-induced pulmonary hypertension by the phosphodiesterase-5 inhibitor Vardenafil
    Stephan Schroll
    Department of Internal Medicine II, Pneumology, University Hospital Regensburg, Germany
    Respir Physiol Neurobiol 186:61-4. 2013
  3. doi request reprint Effects of selective and unselective endothelin-receptor antagonists on prostacyclin synthase gene expression in experimental pulmonary hypertension
    S Schroll
    Department of Internal Medicine II, Pneumology, University of Regensburg, Germany
    Scand J Clin Lab Invest 68:270-6. 2008
  4. doi request reprint Improvement of bleomycin-induced pulmonary hypertension and pulmonary fibrosis by the endothelin receptor antagonist Bosentan
    Stephan Schroll
    Department of Internal Medicine II, Pneumology, University of Regensburg, Regensburg, Germany
    Respir Physiol Neurobiol 170:32-6. 2010
  5. ncbi request reprint Acute haemodynamic effects of continuous positive airway pressure in awake patients with heart failure
    Stephan Schroll
    Department of Internal Medicine II, Pneumology, University Hospital Regensburg, Regensburg
    Respirology 19:47-52. 2014
  6. ncbi request reprint Time course of continuous positive airway pressure effects on central sleep apnoea in patients with chronic heart failure
    Michael Arzt
    Department of Internal Medicine II, University of Regensburg, Regensburg, Germany
    J Sleep Res 18:20-5. 2009
  7. ncbi request reprint Auto-servoventilation in heart failure with sleep apnoea: a randomised controlled trial
    Michael Arzt
    Division of Respirology, University Hospital Regensburg, Regensburg
    Eur Respir J 42:1244-54. 2013
  8. doi request reprint Impact of right ventricular reserve on exercise capacity and survival in patients with pulmonary hypertension
    Friedrich C Blumberg
    Department of Internal Medicine II, University of Regensburg, Regensburg, Germany
    Eur J Heart Fail 15:771-5. 2013
  9. doi request reprint Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study
    Clemens Jilek
    Department of Internal Medicine II, University Hospital Regensburg, Franz Josef Strauβ Allee 11, 93042 Regensburg, Germany
    Eur J Heart Fail 13:68-75. 2011
  10. ncbi request reprint Predictive significance of the six-minute walk distance for long-term survival in chronic hypercapnic respiratory failure
    Stephan Budweiser
    Center for Pneumology, Donaustauf Hospital, Donaustauf, Germany
    Respiration 75:418-26. 2008

Collaborators

Detail Information

Publications12

  1. doi request reprint Effects of simvastatin on pulmonary fibrosis, pulmonary hypertension and exercise capacity in bleomycin-treated rats
    S Schroll
    Department of Internal Medicine II, Pneumology, University of Regensburg, Regensburg, Germany
    Acta Physiol (Oxf) 208:191-201. 2013
    ..Statins reduce fibroblast activity in vitro and pulmonary hypertension in vivo. We investigated whether Simvastatin exerts beneficial effects on pulmonary fibrosis and pulmonary hypertension in Bleomycin-treated rats in vivo...
  2. doi request reprint Improvement of exercise capacity in monocrotaline-induced pulmonary hypertension by the phosphodiesterase-5 inhibitor Vardenafil
    Stephan Schroll
    Department of Internal Medicine II, Pneumology, University Hospital Regensburg, Germany
    Respir Physiol Neurobiol 186:61-4. 2013
    ..In conclusion, Vardenafil exerts beneficial effects on monocrotaline-induced pulmonary hypertension in rats. Whether it is a treatment option for patients with pulmonary hypertension needs to be elucidated...
  3. doi request reprint Effects of selective and unselective endothelin-receptor antagonists on prostacyclin synthase gene expression in experimental pulmonary hypertension
    S Schroll
    Department of Internal Medicine II, Pneumology, University of Regensburg, Germany
    Scand J Clin Lab Invest 68:270-6. 2008
    ..Our hypothesis was that treatment with Ambrisentan leads to an increase in prostacyclin synthase I (PGIS) expression compared to Bosentan...
  4. doi request reprint Improvement of bleomycin-induced pulmonary hypertension and pulmonary fibrosis by the endothelin receptor antagonist Bosentan
    Stephan Schroll
    Department of Internal Medicine II, Pneumology, University of Regensburg, Regensburg, Germany
    Respir Physiol Neurobiol 170:32-6. 2010
    ..Therefore, we investigated the effects of Bosentan on the development of PH in the model of Bleomycin-induced PF in rats...
  5. ncbi request reprint Acute haemodynamic effects of continuous positive airway pressure in awake patients with heart failure
    Stephan Schroll
    Department of Internal Medicine II, Pneumology, University Hospital Regensburg, Regensburg
    Respirology 19:47-52. 2014
    ..The aim of the present study was to test whether incremental CPAP application in awake CHF patients with SDB, with and without atrial fibrillation, induces acute alterations of blood pressure (BP), heart rate (HR) and CO...
  6. ncbi request reprint Time course of continuous positive airway pressure effects on central sleep apnoea in patients with chronic heart failure
    Michael Arzt
    Department of Internal Medicine II, University of Regensburg, Regensburg, Germany
    J Sleep Res 18:20-5. 2009
    ....
  7. ncbi request reprint Auto-servoventilation in heart failure with sleep apnoea: a randomised controlled trial
    Michael Arzt
    Division of Respirology, University Hospital Regensburg, Regensburg
    Eur Respir J 42:1244-54. 2013
    ..The data support that such patients can be randomised in large-scale, long-term trials of positive airway pressure therapy versus control to determine effects on cardiovascular outcome...
  8. doi request reprint Impact of right ventricular reserve on exercise capacity and survival in patients with pulmonary hypertension
    Friedrich C Blumberg
    Department of Internal Medicine II, University of Regensburg, Regensburg, Germany
    Eur J Heart Fail 15:771-5. 2013
    ..We therefore correlated exercise haemodynamics with peak oxygen uptake (peakVO2) and determined their prognostic significance...
  9. doi request reprint Prognostic impact of sleep disordered breathing and its treatment in heart failure: an observational study
    Clemens Jilek
    Department of Internal Medicine II, University Hospital Regensburg, Franz Josef Strauβ Allee 11, 93042 Regensburg, Germany
    Eur J Heart Fail 13:68-75. 2011
    ..The objective of this observational study was to evaluate whether SDB is a risk factor for mortality in CHF patients and whether this risk can be attenuated by treatment with positive airway pressure (PAP)...
  10. ncbi request reprint Predictive significance of the six-minute walk distance for long-term survival in chronic hypercapnic respiratory failure
    Stephan Budweiser
    Center for Pneumology, Donaustauf Hospital, Donaustauf, Germany
    Respiration 75:418-26. 2008
    ..The 6-min walk distance (6-MWD) is a global marker of functional capacity and prognosis in chronic obstructive pulmonary disease (COPD), but less explored in other chronic respiratory diseases...
  11. ncbi request reprint Activation of bronchial epithelial cells in smokers without airway obstruction and patients with COPD
    Christian Schulz
    Klinik und Poliklinik fur Innere Medizin II, Bereich Pneumologie, Klinikum der Universitat Regensburg, Regensburg, Germany
    Chest 125:1706-13. 2004
    ..In addition, the expression of both TNF-alpha-receptor subtypes--p55 TNF-receptor subtype (TNF-R55) and p75 TNF-receptor subtype (TNF-R75)--was quantified in PBECs...
  12. ncbi request reprint Effects of dynamic bilevel positive airway pressure support on central sleep apnea in men with heart failure
    Michael Arzt
    Department of Internal Medicine II, University of Regensburg, Franz Josef Straubeta Allee 11, 93042 Regensburg, Germany
    Chest 134:61-6. 2008
    ..Our objective was to test the hypothesis that flow-targeted dynamic bilevel positive airway pressure (BPAP) support (BiPAP autoSV; Respironics; Murrysville, PA) effectively suppresses CSR-CSA in CHF patients...